LEMULSA Trademark

Trademark Overview


On Wednesday, October 18, 2017, a trademark application was filed for LEMULSA with the United States Patent and Trademark Office. The USPTO has given the LEMULSA trademark a serial number of 87650938. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 10, 2020. This trademark is owned by Lemulsa Technologies Inc.. The LEMULSA trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of prescription pharmaceuticals; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of prescription pharmaceuticals; Medicinal prescription preparations for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, an oral preparation for the treatment of erectile dysfunction prescribed by medical doctors; Prescription pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, derm...
lemulsa

General Information


Serial Number87650938
Word MarkLEMULSA
Filing DateWednesday, October 18, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of prescription pharmaceuticals; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of prescription pharmaceuticals; Medicinal prescription preparations for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, an oral preparation for the treatment of erectile dysfunction prescribed by medical doctors; Prescription pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Therapeutic prescription pharmaceutical for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceuticals for use as a dietary supplement; Medicated cosmetics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLemulsa Technologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDover, DE 19803

Party NameLemulsa Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, DE 19803

Trademark Events


Event DateEvent Description
Friday, October 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 10, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 10, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 4, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, April 4, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 4, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, April 4, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 19, 2018NON-FINAL ACTION E-MAILED
Wednesday, September 19, 2018NON-FINAL ACTION WRITTEN
Thursday, August 23, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, August 23, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 23, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, August 23, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, February 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 2, 2018NON-FINAL ACTION E-MAILED
Friday, February 2, 2018NON-FINAL ACTION WRITTEN
Friday, January 26, 2018ASSIGNED TO EXAMINER
Friday, October 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 21, 2017NEW APPLICATION ENTERED